Management of close margins in invasive breast cancer

Breast Cancer Online

Volumn 10, Issue 2, 2007, Pages

  Bleicher, Richard J ^a   Morrow, M ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast neoplasms; Breast pathology; Breast pathology radiotherapy surgery; Carcinoma; Chemotherapy, adjuvant; Cohort studies; Combined modality therapy; Disease free survival; Ductal; Female; Follow up studies; Humans; Lobular pathology radiotherapy surgery; Mastectomy, segmental; Neoplasm recurrence, local; Radiotherapy, adjuvant; Reoperation; Risk factors; Treatment failure

Indexed keywords

AGE DISTRIBUTION; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; EUROPE; HISTOPATHOLOGY; HUMAN; INDIVIDUALIZATION; INVASIVE CARCINOMA; MASTECTOMY; MINIMAL RESIDUAL DISEASE; NORTH AMERICA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; TREATMENT OUTCOME;

EID: 33947504993     PISSN: 14709031     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1470903107005482     Document Type: Review

References (29)

1. Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1985; 312: 665-673.
2. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347: 1227-1232.
3. Arriagada R, Le MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: Patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 1996; 14: 1558-1564.
4. Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: The National Cancer Institute Randomized Trial. Cancer 2003; 98: 697-702.
5. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000; 92: 1143-1150.
6. Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 1992; Issue #11: 19-25.
7. Fentiman IS. Long-term follow-up of the first breast conservation trial (Guy's Wide Excision Study). Eur J Cancer 1998; 34: S37-S38.
8. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002; 347: 567-575.
9. Taghian A, Mohiuddin M, Jagsi R, Goldberg S, Ceilley E, Powell S. Current perceptions regarding surgical margin status after breast-conserving therapy: Results of a survey. Ann Surg 2005; 241: 629-639.
10. Smitt MC, Nowels KW, Zdeblick MJ, et al. The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 1995; 76: 259-267.
11. Obedian E, Haffty BG. Negative margin status improves local control in conservatively managed breast cancer patients. Cancer J Sci Am 2000; 6: 28-33.
12. Neuschatz AC, DiPetrillo T, Steinhoff M, et al. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast. Cancer 2002; 94: 1917-1924.
13. Dooley WC, Parker J. Understanding the mechanisms creating false positive lumpectomy margins. Am J Surg 2005; 190: 606-608.
14. Luu HH, Otis CN, Reed Jr WP, Garb JL, Frank JL. The unsatisfactory margin in breast cancer surgery. Am J Surg 1999; 178: 362-366.
15. Neuschatz AC, DiPetrillo T, Safaii H, Price LL, Schmidt-Ullrich RK, Wazer DE. Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy. Cancer 2003; 97: 30-39.
16. Darvishian F, Hajdu SI, DeRisi DC. Significance of linear extent of breast carcinoma at surgical margin. Ann Surg Oncol 2003; 10: 48-51.
17. Gage I, Schnitt SJ, Nixon AJ, et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 1996; 78: 1921-1928.
18. Holland R, Connolly JL, Gelman R, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990; 8: 113-118.
19. Smitt MC, Nowels K, Carlson RW, Jeffrey SS. Predictors of reexcision findings and recurrence after breast conservation. Int J Radiat Oncol Biol Phys 2003; 57: 979-985.
20. Wazer DE, Schmidt-Ullrich RK, Schmid CH, et al. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden. Int J Radiat Oncol Biol Phys 1997; 38: 291-299.
21. Dillon MF, Hill AD, Quinn CM, McDermott EW, O'Higgins N. A pathologic-assessment of adequate margin status in breast-conserving therapy. Ann Surg Oncol 2006; 13: 333-339.
22. Bartelink H, Horiot JC, Poortmans P, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001; 345: 1378-1387.
23. Pass H, Vicini FA, Kestin LL, et al. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution. Cancer 2004; 101: 713-720.
24. Wapnir I, Anderson S, Mamounas E, et al. Survival after IBTR in NSABP Node Negative Protocols B-13, B-14, B-19, B-20 and B-23. In: Grunberg SM (Ed.). ASCO 41st Annual Meeting, Vol. 23. Orlando, FL: Lisa Greaves; 2005: 8s.
25. Gibson GR, Lesnikoski BA, Yoo J, Mott LA, Cady B, Barth Jr RJ. A comparison of ink-directed and traditional whole-cavity re-excision for breast lumpectomy specimens with positive margins. Ann Surg Oncol 2001; 8: 693-704.
26. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233-1241.
27. Freedman G, Fowble B, Hanlon A, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 1999; 44: 1005-1015.
28. Park CC, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence. J Clin Oncol 2000; 18: 1668-1675.
29. Wazer DE, Jabro G, Ruthazer R, Schmid C, Safaii H, Schmidt-Ullrich RK. Extent of margin positivity as a predictor for local recurrence after breast conserving irradiation. Radiat Oncol Investig 1999; 7: 111-117.